Casondra Banks, PA
Physician Assistant · Pensacola, FLNPI 1679562136
Payments from drug & device makers
Across 97 payments — averaging $19.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$606
- Regeneron Healthcare Solutions, Inc.$262
- Johnson & Johnson$209
- Novartis$193
- Sanofi$175
- Lilly USA, LLC$151
- plus $324 from 8 others
What the payments were for
- Food & beverage$1,920100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $606 |
| Regeneron Healthcare Solutions, Inc. | 13 | $262 |
| Johnson & Johnson | 11 | $209 |
| Novartis | 10 | $193 |
| Sanofi | 7 | $175 |
| Lilly USA, LLC | 6 | $151 |
| E.r. Squibb & Sons, L.L.C. | 5 | $108 |
| Galderma Laboratories, L.p. | 5 | $100 |
| LEO Pharma Inc. | 2 | $35 |
| UCB, Inc. | 1 | $22 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
| Verrica Pharmaceuticals Inc. | 1 | $15 |
| Pfizer | 1 | $14 |
| Incyte Corporation | 1 | $13 |
How this compares
$1,920 in reported general payments places this provider in the 75th percentile of 8,062 physician assistant providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 15 | $131,848 |
| Dupixent PenDupilumab | 27 | $98,796 |
| Fluorouracil | 84 | $6,573 |
| Triamcinolone Acetonide | 458 | $5,717 |
| Clobetasol Propionate | 118 | $4,608 |
| Ketoconazole | 186 | $4,285 |
| Fluocinonide | 94 | $4,052 |
| Tretinoin | 39 | $3,131 |
| Tacrolimus | 15 | $2,372 |
| Metronidazole | 30 | $1,642 |
| Doxycycline Monohydrate | 68 | $1,485 |
| MethotrexateMethotrexate Sodium | 98 | $1,260 |
| Cephalexin | 25 | $1,138 |
| Ammonium Lactate | 36 | $966 |
| Clindamycin Phosphate | 19 | $834 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Pensacola
- Christopher SmithPensacola$82K
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.